These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¨
|
Preliminary Proxy Statement
|
|
¨
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
x
|
Definitive Proxy Statement
|
|
¨
|
Definitive Additional Materials
|
|
¨
|
Soliciting Material Pursuant to §240.14a-12
|
|
x
|
No fee required
|
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
|
Total fee paid:
|
|
¨
|
Fee paid previously with preliminary materials.
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
Filing Party:
|
|
|
(4)
|
Date Filed:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sincerely,
|
|
|
|
|
|
|
|
|
||||
|
March 11, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
Brian O. Casey
|
|
|
|||
|
|
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
WESTWOOD MANAGEMENT • WESTWOOD TRUST • WESTWOOD ADVISORS • WESTWOOD INTERNATIONAL ADVISORS
200 CRESCENT COURT, SUITE 1200 • DALLAS, TEXAS 75201 • T.214.756.6900 • F.214.756.6979 • www.westwoodgroup.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
|
|
|
|
|
||
|
|
|
|||
|
NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS
|
|
|
ii
|
|
|
|
|
|||
|
|
|
|
||
|
The Annual Meeting
|
|
|
1
|
|
|
Procedures for Voting
|
|
|
2
|
|
|
Our Current Stock Ownership
|
|
|
3
|
|
|
Other Information
|
|
|
4
|
|
|
|
|
|||
|
|
|
|
||
|
Nominees
|
|
|
5
|
|
|
Corporate Governance Information
|
|
|
8
|
|
|
Director Compensation
|
|
|
12
|
|
|
|
|
|||
|
|
|
|
||
|
|
|
|||
|
|
|
|
||
|
Compensation Discussion and Analysis
|
|
|
15
|
|
|
Compensation Committee Report
|
|
|
27
|
|
|
Summary Compensation Table
|
|
|
27
|
|
|
Grants of Plan-Based Awards
|
|
|
29
|
|
|
Outstanding Equity Awards at Fiscal Year-End
|
|
|
31
|
|
|
Stock Vested
|
|
|
32
|
|
|
Potential Payments Upon Termination or Change in Control
|
|
|
32
|
|
|
|
|
|||
|
|
|
|
||
|
Fees Billed by Independent Registered Public Accounting Firms
|
|
|
42
|
|
|
Vote Sought and Recommendation
|
|
|
42
|
|
|
|
|
|||
|
|
|
|
||
|
Effect of Proposal
|
|
|
43
|
|
|
Material Features of the Plan
|
|
|
44
|
|
|
Material Federal Income Tax Consequences of the Plan
|
|
|
46
|
|
|
Vote Sought and Recommendation
|
|
|
48
|
|
|
|
|
|||
|
|
|
|
||
|
|
|
|||
|
|
|
|
||
|
|
|
|||
|
|
|
|
||
|
|
|
|||
|
|
|
|
||
|
|
|
|||
|
|
|
|
||
|
|
|
|||
|
|
|
|
||
|
|
|
|||
|
|
|
|
||
|
|
|
|||
|
|
|
|
||
|
|
|
|||
|
|
|
|
||
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
Proposal 1.
|
|
The election of eight directors to hold office until the next annual meeting of Westwood’s stockholders and until their respective successors shall have been duly elected and qualified;
|
|
|
|
|
|
Proposal 2.
|
|
The ratification of the appointment of Deloitte & Touche LLP as Westwood’s independent auditors for the year ending December 31, 2016; and
|
|
|
|
|
|
Proposal 3.
|
|
The approval of the material terms of the Third Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan, as amended from time to time, for purposes of complying with the requirements of Section 162(m) of the Internal Revenue Code of 1986, as amended.
|
|
|
|
By Order of the Board of Directors
|
|
Westwood Holdings Group, Inc.
|
|
|
|
|
Brian O. Casey
|
|
President and Chief Executive Officer
|
|
Q:
|
When and where is the annual meeting?
|
|
A:
|
The annual meeting will be held on Wednesday, April 27, 2016, at 10:00 a.m., Central time, at The Crescent Club, 200 Crescent Court, Suite 1700, Dallas, Texas 75201.
|
|
Q:
|
What am I being asked to vote on?
|
|
A:
|
Our stockholders are being asked to vote on the following proposals at the annual meeting:
|
|
|
|
•
|
To elect eight directors to hold office until the next annual meeting of Westwood’s stockholders and until their respective successors shall have been duly elected and qualified;
|
|
|
•
|
To ratify the appointment of Deloitte & Touche LLP as Westwood’s independent auditors for the year ending December 31, 2016; and
|
|
|
•
|
To approve the material terms of the Third Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan, as amended from time to time, for purposes of complying with the requirements of Section 162(m) of the Internal Revenue Code of 1986, as amended.
|
|
Q:
|
How does the Board of Directors recommend that I vote?
|
|
A:
|
The Board of Directors recommends that you vote your shares (i) “FOR” each of the eight director nominees for election to the Board of Directors, (ii) “FOR” the ratification of the appointment of Deloitte & Touche LLP as Westwood’s independent auditors for the year ending December 31, 2016, and (iii) “FOR” the approval of the material terms of the Third Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan, as amended from time to time, for purposes of complying with the requirements of Section 162(m) of the Internal Revenue Code of 1986, as amended.
|
|
|
If you submit your properly executed proxy without voting instructions, your shares represented by that proxy will be voted as recommended by the Board of Directors.
|
|
Q:
|
Who is entitled to vote at the annual meeting?
|
|
A:
|
Stockholders of record at the close of business on March 7, 2016 (the “record date”) are entitled to notice of, and to vote at, the annual meeting and any adjournments or postponements thereof. A holder of shares of our common stock as of the record date is entitled to one vote in person or by proxy for each share of common stock owned by such holder on all matters properly brought before the annual meeting or at any adjournments or postponements thereof. As of March 7, 2016, there were 8,738,986 shares of common stock outstanding and entitled to vote on each of the proposals.
|
|
Q:
|
What constitutes a quorum?
|
|
A:
|
In order to carry on the business of the annual meeting, we must have a quorum. This means at least a majority of the shares of common stock outstanding as of the record date must be represented at the annual meeting, either by proxy or in person. Abstentions and broker non-votes, which are described in more detail below, are counted as shares present at the annual meeting for purposes of determining whether a quorum exists.
|
|
Q:
|
What is the difference between holding shares as a “stockholder of record” and as a “beneficial owner”?
|
|
A:
|
Stockholder of Record: A stockholder of record holds shares registered directly in the stockholder's name with our transfer agent. As a stockholder of record, you have the right to grant your voting proxy directly to us in accordance with the procedures described below or to vote in person at the annual meeting.
|
|
|
Beneficial Owner: If your shares are held through a bank, broker or other nominee, you are the “beneficial owner” of shares held in “street name,” and these proxy materials are being forwarded to you by your bank, broker or other nominee, which is considered, with respect to those shares, the stockholder of record. As the beneficial owner, you have the right to direct your bank, broker or other nominee on how to vote your shares by completing the instructions provided to you by your bank, broker or other nominee. However, since you are not a stockholder of record, you may not vote these shares in person at the annual meeting unless you obtain a valid proxy from your bank, broker or other nominee (who must be the stockholder of record) giving you the right to vote the shares.
|
|
Q:
|
What is a broker non-vote?
|
|
A:
|
Generally, a broker non-vote occurs when a bank, broker or other nominee that holds shares in “street name” for customers is precluded from exercising voting discretion on a particular proposal because (i) the beneficial owner has not instructed the bank, broker or other nominee how to vote, and (ii) the bank, broker or other nominee lacks discretionary voting power to vote such shares. A bank, broker or other nominee does not have discretionary voting power with respect to the approval of “non-routine” matters absent specific voting instructions from the beneficial owners of such shares.
|
|
|
Under applicable rules, Proposals 1 and 3 are considered “non-routine” matters, on which banks, brokers and other nominees are not allowed to vote unless they have received voting instructions from the beneficial owners of such shares. The proposal to ratify the appointment of Deloitte & Touche LLP as Westwood’s independent auditor for the year ending December 31, 2016 (Proposal 2) is considered a routine matter on which banks, brokers and other nominees may vote in their discretion on behalf of beneficial owners who have not provided voting instructions. Your bank, broker or other nominee will send you instructions on how you can instruct them to vote on Proposal 2. If you do not provide voting instructions, your bank, broker or other nominee will have discretionary authority to vote your shares with respect to Proposal 2.
|
|
Q:
|
What vote is required to approve each proposal?
|
|
A:
|
Proposal 1: The election of directors requires the affirmative “FOR” vote of a plurality of the shares represented in person or by proxy at the annual meeting and entitled to vote. This means that the eight director nominees who receive the most votes will be elected. You may vote “FOR” or “WITHHOLD” with respect to the election of each director. As the election of directors is a non-routine matter under applicable rules, your bank, broker or other nominee cannot vote without instructions from you. Therefore, only “FOR” votes will be counted in determining whether a plurality has been cast in favor of a director. Broker non-votes and “WITHHOLD” votes will not affect the outcome on the election of directors.
|
|
|
Proposal 2: The ratification of the appointment of Deloitte & Touche LLP as Westwood’s independent auditors for the year ending December 31, 2016 requires the affirmative “FOR” vote of a majority of the votes cast at the annual meeting. Abstentions will have no effect on the outcome of this proposal.
|
|
|
Proposal 3: The approval of the material terms of the Third Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan, as amended from time to time, for purposes of complying with the requirements of Section 162(m) of the Internal Revenue Code of 1986, as amended, requires the affirmative “FOR” vote of a majority of the votes cast at the annual meeting (provided that the total votes cast upon this proposal represent over fifty percent (50%) of all shares entitled to vote on this proposal). As the approval of Proposal 3 is a non-routine matter under applicable rules, your bank, broker or other nominee cannot vote without instructions from you. An abstention is a vote cast under current NYSE rules, and, as a result, abstentions will have the effect of a vote “AGAINST” this proposal. A broker non-vote, however, is not a vote cast under current NYSE rules, and, as a result, will have no effect on the outcome of this proposal.
|
|
Q:
|
Who is entitled to vote?
|
|
A:
|
Only stockholders of record as of the close of business on March 7, 2016, the record date, will be entitled to vote on the proposals at the annual meeting. Each share of common stock is entitled to one vote.
|
|
Q:
|
How do I vote?
|
|
A:
|
If you are the record holder of your shares, you can vote by attending the annual meeting in person or by completing, signing and returning your proxy card in the enclosed postage-paid envelope. You can also vote by Internet at www.voteproxy.com using the control number shown on your proxy card or voting instruction card.
|
|
|
If your shares are held by your broker as your nominee (that is, in “street name”), you will need to obtain a proxy form from the institution that holds your shares and follow the instructions included on that form regarding how to instruct your broker to vote your shares. If your shares are held in street name, your proxy card may contain instructions from your broker that allow you to vote your shares using the Internet or telephone. Please consult with your broker if you have any questions regarding the electronic voting of shares held in street name.
|
|
Q:
|
Is my proxy revocable and can I change my vote?
|
|
A:
|
If you are a stockholder of record you may revoke your proxy at any time before it is voted by doing one of the following:
|
|
|
|
•
|
Sending a written notice revoking your proxy to Julie K. Gerron, our Corporate Secretary, at 200 Crescent Court, Suite 1200, Dallas, Texas 75201;
|
|
|
•
|
Signing and mailing to us a proxy bearing a later date;
|
|
|
•
|
Changing your vote by Internet (if you voted by Internet); or
|
|
|
•
|
Attending our annual meeting and voting in person.
|
|
|
|
|
|
|
If you are not a stockholder of record, but instead hold your shares in “street name” through a bank, broker or other nominee, the above-described options for revoking your proxy do not apply. Instead, you will need to follow the instructions provided to you by your bank, broker or other nominee in order to revoke your proxy and submit new voting instructions.
|
|
|
Q:
|
Is my vote confidential?
|
|
A:
|
Yes. Only the inspector of votes and certain of our employees will have access to your proxy card. All comments will remain confidential, unless you ask that your name be disclosed.
|
|
Q:
|
What percentage of stock do the directors and executive officers own?
|
|
A:
|
Collectively, our executive officers and directors beneficially owned approximately 869,186 shares, or approximately 10.1%, of our outstanding common stock as of March 7, 2016.
|
|
|
We believe that our executive officers and directors intend to vote their shares of our common stock on each of the proposals presented in this proxy statement as recommended by the Board of Directors.
|
|
Q:
|
Who are the largest principal stockholders?
|
|
A:
|
Based on our review of Schedule 13G, Schedule 13D and Form 13F filings, as of March 7, 2016, the ten institutional stockholders with the largest percentage ownership of our outstanding common stock were Royce & Associates, LLC (8.2%), GAMCO Investors, Inc. (7.2%), BlackRock, Inc. (6.2%), Wells Capital Management, Inc. (5.5%), Conestoga Capital Advisors LLC (5.2%), Wellington Management Co LLP (4.7%), The Vanguard Group, Inc. (2.7%), Dimensional Fund Advisors LP (2.4%), Renaissance Technologies LLC (2.2%) and Punch & Associates Inv Management Inc (1.8%).
|
|
|
Susan M. Byrne, our Vice Chairman, owned 3.8%, Brian O. Casey, our President and Chief Executive Officer, owned 2.9% and Mark R. Freeman, our Chief Investment Officer, owned 1.0%, of our outstanding common stock as of March 7, 2016. Our employees and directors, including Ms. Byrne and Messrs. Casey and Freeman, collectively owned approximately 26% of our outstanding common stock as of March 7, 2016.
|
|
Q:
|
What is the deadline to propose actions for consideration at the 2017 annual meeting of stockholders?
|
|
A:
|
To be included in the proxy statement for the 2017 annual meeting, stockholder proposals must be in writing and must be received by Westwood at our principal executive office at 200 Crescent Court, Suite 1200, Dallas, Texas 75201, Attn: Corporate Secretary, no later than November 18, 2016. In addition, such stockholder proposals must comply with Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which lists the requirements for the inclusion of stockholder proposals in company-sponsored proxy materials.
|
|
|
If a stockholder intends to present a proposal at the 2017 annual meeting, but does not seek to include the proposal in the proxy statement, notice of the proposal must be received by Westwood at our principal executive offices at least 45 calendar days before the date of this proxy statement, or your proxy will confer discretionary authority on the person(s) named in the form of proxy for the 2017 annual meeting to vote on the proposal if it is properly presented for consideration at the meeting.
|
|
Q:
|
How may I recommend or nominate individuals to serve as directors, and what is the deadline to propose or nominate individuals to serve as directors?
|
|
A:
|
You may propose director candidates for consideration by the Governance/Nominating Committee of our Board of Directors. Any such recommendations must be in writing to our Corporate Secretary at our principal executive office and received not fewer than 120 calendar days before the one-year anniversary of the date that the proxy statement for the previous year’s annual meeting was released to stockholders. However, if we did not hold an annual meeting during the previous year, or if the date of the current year’s annual meeting has been changed by more than 30 days from the date of the previous year’s annual meeting, then the deadline is a reasonable time before we begin to print and mail our proxy materials.
|
|
|
For the 2017 annual meeting, the deadline for proposing or nominating individuals to serve as director is November 18, 2016. Director candidates recommended by stockholders are evaluated by the Governance/Nominating Committee based on the same criteria applied by the Governance/Nominating Committee to director candidates identified by that committee. To be valid, a stockholder’s notice to the Corporate Secretary must set forth specified information, as further described in “Corporate Governance Information—Director Nominees.”
|
|
Q:
|
Who is soliciting my proxy and who will pay the solicitation expenses?
|
|
A:
|
The Company is soliciting your proxy by and on behalf of our Board of Directors, and we will pay the cost of preparing and distributing this proxy statement and the cost of soliciting votes. We will reimburse stockbrokers and other custodians, nominees and fiduciaries for forwarding proxy and solicitation material to the owners of our common stock.
|
|
Q:
|
Who can help answer my additional questions?
|
|
A:
|
Stockholders who would like additional copies, without charge, of this proxy statement or have additional questions about this proxy statement, including the procedures for voting their shares, should contact:
|
|
|
Tiffany B. Kice, Chief Financial Officer & Treasurer
Westwood Holdings Group, Inc.
200 Crescent Court, Suite 1200
Dallas, Texas 75201
Telephone: (214) 756-6900
|
|
|
|
|
|
|
Name
|
Age
|
|
Position(s) With Westwood
|
|
Brian O. Casey
|
52
|
|
President, Chief Executive Officer and Director
|
|
|
|
|
|
|
Richard M. Frank
|
68
|
|
Chairman of the Board of Directors
|
|
|
|
|
|
|
Susan M. Byrne
|
69
|
|
Vice Chairman of the Board of Directors
|
|
|
|
|
|
|
Ellen H. Masterson
|
65
|
|
Director
|
|
|
|
|
|
|
Robert D. McTeer
|
73
|
|
Director
|
|
|
|
|
|
|
Geoffrey R. Norman
|
72
|
|
Director
|
|
|
|
|
|
|
Martin J. Weiland
|
67
|
|
Director
|
|
|
|
|
|
|
Raymond E. Wooldridge
|
77
|
|
Director
|
|
|
|
|
|
|
|
|
|
Independent Directors (1)
|
|
Audit
Committee
|
|
Compensation
Committee
|
|
Governance/Nominating
Committee
|
|
Richard M. Frank (2)
|
|
M
|
|
C
|
|
M
|
|
Ellen H. Masterson (3)(4)
|
|
M
|
|
|
|
M
|
|
Robert D. McTeer
|
|
|
|
|
|
M
|
|
Geoffrey R. Norman (3)
|
|
M
|
|
|
|
M
|
|
Martin J. Weiland
|
|
|
|
M
|
|
C
|
|
Raymond E. Wooldridge
|
|
C
|
|
M
|
|
M
|
|
(1)
|
The Board of Directors has determined that all members of the Audit, Compensation and Governance/Nominating Committees are “independent directors” under the applicable rules of the NYSE and the Securities and Exchange Commission ("SEC").
|
|
(2)
|
Richard M. Frank is the Chairman of the Board of Directors and, as such, he chairs executive sessions of the Board of Directors.
|
|
(3)
|
The Board of Directors has determined that Geoffrey R. Norman and Ellen H. Masterson are qualified as Audit Committee financial experts within the meaning of the regulations of the SEC and have accounting and related financial management expertise within the meaning of the NYSE Corporate Governance Listing Standards.
|
|
(4)
|
Ellen H. Masterson will replace Raymond E. Wooldridge as the Chair of the Audit Committee, to be effective April 27, 2016.
|
|
•
|
Overall compensation levels that are competitive with the market;
|
|
•
|
Limits on annual cash incentive awards;
|
|
•
|
The Compensation Committee’s discretionary authority to reduce annual cash incentive awards;
|
|
•
|
Use of long-term equity incentive awards to reward executives and other key employees for driving sustainable, profitable growth for stockholders and clients;
|
|
•
|
Vesting periods for long-term equity incentive awards that encourage executives and other key employees to focus on sustained stock price appreciation; and
|
|
•
|
The Company’s internal control over financial reporting and other financial, operational and compliance policies and practices currently in place that are intended to prevent manipulation of performance.
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
Fees Earned
or Paid in
Cash
($) |
|
All
Other Compensation ($) (1) |
|
Stock Awards
($) (2) |
|
Total
($) |
|
Susan M. Byrne
(3)
|
|
25,000
|
|
375,000
|
|
90,000
|
|
490,000
|
|
Richard M. Frank
|
|
57,500
|
|
5,000
|
|
95,000
|
|
157,500
|
|
Ellen H. Masterson
|
|
50,000
|
|
5,000
|
|
95,000
|
|
150,000
|
|
Robert D. McTeer
|
|
50,000
|
|
5,000
|
|
95,000
|
|
150,000
|
|
Geoffrey R. Norman
|
|
50,000
|
|
5,000
|
|
95,000
|
|
150,000
|
|
Martin J. Weiland
|
|
55,000
|
|
5,000
|
|
95,000
|
|
155,000
|
|
Raymond E. Wooldridge
|
|
57,500
|
|
5,000
|
|
95,000
|
|
157,500
|
|
(1)
|
Susan M. Byrne earned $250,000 as a salaried employee of the Company from January 1, 2015 to June 30, 2015 and $125,000 as a consultant for the Company from July 1, 2015 to December 31, 2015. Each non-employee director also earns a $1,000 annual retainer and $1,000 for each regularly scheduled quarterly meeting for serving on the separate Board of Directors of Westwood Trust.
|
|
(2)
|
Stock awards include a $90,000 award for each non-employee director and a $5,000 award for each non-employee director serving on the separate Board of Directors for Westwood Trust. Stock awards reflect the grant date fair value of the time-based restricted stock granted to directors in 2015 in accordance with Accounting Standards Codification Topic 718 (“ASC 718”), “Stock Compensation” (except no assumptions for forfeitures were included). The assumptions used in the valuation of the restricted stock awards are discussed in Note 9 “Employee Benefits” of our audited financial statements, which are included in our 2015 Annual Report on Form 10-K. All restricted stock grants were made under the Third Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan and are subject to a one-year vesting period as described above.
|
|
(3)
|
Susan M. Byrne earned a $25,000 retainer as Vice Chairman of the Board from July 1, 2015 to December 31, 2015.
|
|
|
|
|
|
|
Name
|
|
Unvested
Restricted Stock |
|
|
Susan M. Byrne
(1)
|
|
1,733
|
|
|
Richard M. Frank
(2)
|
|
1,484
|
|
|
Ellen H. Masterson
(2)
|
|
1,484
|
|
|
Robert D. McTeer
(2)
|
|
1,484
|
|
|
Geoffrey R. Norman
(2)
|
|
1,484
|
|
|
Martin J. Weiland
(2)
|
|
1,484
|
|
|
Raymond E. Wooldridge
(2)
|
|
1,484
|
|
|
(1)
|
Issued on August 21, 2015 and has a vesting date of April 29, 2016, subject to Ms. Byrne’s continued service as a director through the vesting date.
|
|
(2)
|
Issued on April 29, 2015 and have a vesting date of April 29, 2016, subject to such director’s continued service as a director through the vesting date.
|
|
•
|
Brian O. Casey, President and Chief Executive Officer;
|
|
•
|
Tiffany B. Kice, Senior Vice President, Chief Financial Officer & Treasurer;
|
|
•
|
Mark R. Freeman, Executive Vice President and Chief Investment Officer;
|
|
•
|
Julie K. Gerron, Senior Vice President, General Counsel and Corporate Secretary; and
|
|
•
|
Randall L. Root, President, Westwood Trust Dallas
|
|
•
|
Assets under management as of December 31, 2015 were $20.8 billion, a 3% increase compared to $20.2 billion at December 31, 2014; average assets under management for 2015 were $21.5 billion, 9% higher than 2014.
|
|
•
|
Launched three new mutual funds during 2015, bringing the mutual funds now offered to a total of 15.
|
|
•
|
Completed the acquisition of Woodway Financial Advisors on April 1, 2015, bringing Private Wealth assets to 26% of our firm-wide assets under management.
|
|
•
|
Total revenue was a record $130.9 million, a 16% increase over 2014.
|
|
•
|
In October 2015, the Board approved a 14% increase in our quarterly dividend to $0.57 per share, or an annual rate of $2.28, resulting in a dividend yield of 4.4% using the year-end stock price of $52.09 per share.
|
|
•
|
Our financial position remains strong with liquid cash and investments of $95.1 million and no debt as of December 31, 2015.
|
|
|
|
|
|
Maintained base salaries at 2014 levels for Chief Executive Officer, Chief Financial Officer, Chief Investment Officer and President, Westwood Trust Dallas
|
|
Our Chief Executive Officer, Chief Financial Officer, Chief Investment Officer and President, Westwood Trust Dallas did not receive base salary increases in 2015. Ms. Gerron received a base salary increase of 5%.
|
|
|
|
|
|
Each of the named executive officers earned an annual cash incentive
award(s), in part due to strong Company performance
|
|
Messrs. Casey and Freeman received annual cash incentive awards of $2,065,669 and $1,032,835, respectively, based upon our adjusted pre-tax income for 2015 (as defined below under “2015 Executive Compensation Components-Annual Cash Incentive Awards”).
Mr. Freeman earned an award of $1,000,000 based on the Westwood Income Opportunity Fund’s receiving a 4-star overall rating from Morningstar for the fiscal 2015 period. This mutual fund award is scheduled to vest on December 31, 2016 provided Mr. Freeman remains continuously employed by the Company through the vesting date, subject to certain accelerated vesting conditions in the event of termination.
Ms. Kice earned an annual cash incentive award of $250,000 from the Company’s cash bonus pool compared to her 2014 annual cash incentive award of $110,000, which was pro-rated for her service in 2014.
Ms. Gerron earned an annual cash incentive award of $190,000 from the Company's cash bonus pool, unchanged from her 2014 annual cash incentive award.
Mr. Root earned an annual cash incentive award of $250,000, representing a 25% increase from his 2014 annual cash incentive award.
|
|
|
|
|
|
Maintained the number of long-term equity awards at 2014 levels for the Chief Executive Officer and Chief Investment Officer and decreased the long-term equity awards for General Counsel and President, Westwood Trust Dallas
|
|
In connection with their performance-based restricted stock awards, Messrs. Casey and Freeman vested in 35,000 shares and 20,000 shares, respectively, as a result of our achieving 2015 adjusted pre-tax income (as defined below) of at least $46 million.
Ms. Kice. Ms. Gerron and Mr. Root received time-based restricted stock awards of $224,588, $249,515 and $249,515, respectively.
|
|
|
|
|
|
Perquisites were insignificant
|
|
The Company did not provide significant perquisites to the named executive officers in 2015.
|
|
|
|
|
|
A significant portion of the named executive officers’ total direct compensation was “at-risk” compensation
|
|
As shown in the graph below, a significant portion of the named executive officers’ 2015 total direct compensation – ranging from approximately 64% to 87% – represented “at risk” compensation, delivered in the form of annual cash incentive awards and long-term equity awards. This range excludes Ms. Kice, who was entitled to a minimum Annual Cash Incentive Award pursuant to the terms of her offer letter.
|
|
•
|
The Company entered into a new employment agreement with our Chief Executive Officer, Mr. Casey, which provides for the following features:
|
|
◦
|
Three-year term (shortened from a five-year term under the previous agreement);
|
|
◦
|
Double-trigger change-in-control related cash severance, requiring a qualifying termination of employment within 24 months following a qualifying change-in-control event; and
|
|
◦
|
"Net best" treatment for potential excise taxes (no gross-up provided);
|
|
•
|
Stock ownership guidelines for the CEO, certain other executives and members of our Board of Directors have been implemented, requiring the following minimum holdings:
|
|
◦
|
Chief Executive Officer holdings equal 6x base salary;
|
|
◦
|
Officers reporting directly to CEO holdings equal 3x base salary;
|
|
◦
|
Non-employee members of our Board of Directors holdings equal 5x cash retainer; and
|
|
◦
|
For each of the above, those subject to these stock ownership guidelines have up to five years to meet the minimum ownership level and are required to hold 100% of net shares acquired through vesting of equity-based compensation programs until the minimum guideline level is met;
|
|
•
|
Adopted a “clawback” policy allowing our Board of Directors the discretion to recoup incentive compensation earned for performance that was subject to materially misstated financial reporting due to misconduct or fraud;
|
|
•
|
Modified our annual incentive plan for the CEO from a fixed percentage of annual pretax income to a scorecard with multiple pre-established performance goals, to improve the alignment of executive pay with Company performance and to diversify performance metrics so that our short- and long-term incentive plans no longer have significantly overlapping performance criteria;
|
|
•
|
Our long-term incentive program for the CEO for 2016 was also modified from a front-loaded five-year equity award to an annual performance-based award structure equally weighted between two performance-based restricted stock awards, each tied to its own annual adjusted pretax income goal with additional time-based vesting; and
|
|
•
|
Modified the peer group of companies used to benchmark compensation in 2015 (for informing 2016 compensation decisions) to a set of companies more reflective of Westwood’s size, complexity and business.
|
|
•
|
Our anti-hedging and anti-pledging policies prohibit our executives and directors from using short-selling, put or call options, collars or other similar techniques, as well as prohibit our executives and directors from pledging company shares as collateral or holding shares in a margin account;
|
|
•
|
With the adoption of our new CEO incentive program for 2016, our incentive plans include payout caps;
|
|
•
|
We benchmark the compensation of our officers against industry survey data and against a select set of industry peers (our “peer group”) so that the Compensation Committee considers current market practices when setting market-based pay levels and in making compensation decisions; and
|
|
•
|
The Company does not back-date, re-price or grant equity awards retroactively.
|
|
•
|
Deliver competitive total direct compensation at levels to attract, motivate and retain talented executives who can contribute to the success of our business;
|
|
•
|
Award compensation that motivates and rewards short and long-term individual and company performance; and
|
|
•
|
Align named executive officers’ interests with those of our stockholders.
|
|
|
|
|
|
• Artisan Partners Asset Management
|
|
• Manning & Napier
|
|
• Calamos Asset Management, Inc.
|
|
• OM Asset Management Plc
|
|
• Cohen & Steers, Inc.
|
|
• Pzena Investment Management, Inc.
|
|
• Diamond Hill Investment Group, Inc.
|
|
• Silvercrest Asset Management Group, Inc.
|
|
• Federated Investors, Inc.
|
|
• Virtus Investment Partners, Inc.
|
|
• GAMCO Investors, Inc.
|
|
• WisdomTree Investments Inc.
|
|
• Janus Capital Group Inc.
|
|
|
|
•
|
Base salary;
|
|
•
|
Annual cash incentive awards;
|
|
•
|
Long-term equity awards; and
|
|
•
|
Employee and post-retirement benefits.
|
|
|
|
|
|
|
|
|
|||||
|
Named Executive Officers
|
|
Base Salary
as of 1/1/15 |
|
Base Salary
as of 12/31/15 |
|
Percentage
Change |
|||||
|
Brian O. Casey,
President and Chief Executive Officer
|
|
$
|
600,000
|
|
|
$
|
600,000
|
|
|
—
|
|
|
Tiffany B. Kice,
Senior Vice President, Chief Financial Officer & Treasurer
|
|
$
|
225,000
|
|
|
$
|
225,000
|
|
|
—
|
|
|
Mark R. Freeman,
Executive Vice President and Chief Investment Officer
|
|
$
|
500,000
|
|
|
$
|
500,000
|
|
|
—
|
|
|
Julie K. Gerron,
Senior Vice President, General Counsel and Corporate Secretary
|
|
$
|
200,000
|
|
|
$
|
210,000
|
|
|
5
|
%
|
|
Randall L. Root,
President, Westwood Trust Dallas
|
|
$
|
250,000
|
|
|
$
|
250,000
|
|
|
—
|
|
|
•
|
Investment performance (25% weighting);
|
|
•
|
Service and sales (25% weighting);
|
|
•
|
Financial results (25% weighting); and
|
|
•
|
Strategic initiatives (25% weighting).
|
|
Name
|
|
2015 Annual Incentive Payout
|
|
Determining Factors
|
|||
|
Tiffany B. Kice
(1)
|
|
$
|
250,000
|
|
|
|
Contributions to the Company’s strategic initiatives, including corporate development, financial and tax planning;
|
|
|
Contributions towards the acquisition of Woodway Financial Advisors - A Westwood Trust Company;
|
||||||
|
|
Membership on the Company’s Information Technology Steering Committee and Risk Management and Disclosure Committee; and
|
||||||
|
|
Firm-wide oversight and enhancements of our financial reporting process and internal control over financial reporting.
|
||||||
|
Julie K. Gerron
|
|
$
|
190,000
|
|
|
|
Management and oversight of our compliance with legal and regulatory requirements;
|
|
|
Management and oversight of risk management issues, including review and negotiation of legal agreements and participation in internal risk management committees;
|
||||||
|
|
Oversight of external counsel with a goal toward timely resolution of legal issues (e.g. litigation, trademark issues, corporate governance, etc.);
|
||||||
|
|
Contributions towards the acquisition of Woodway Financial Advisors - A Westwood Trust Company; and
|
||||||
|
|
Effective representation of our legal and compliance program and processes to clients, investment consulting firms and other financial intermediaries.
|
||||||
|
Randall L. Root
|
|
$
|
250,000
|
|
|
|
Oversight responsibilities for the Westwood Trust home office and leadership of the Westwood Trust Investment Committee and Asset Allocation Committee; and
|
|
|
Contributions towards the acquisition of Woodway Financial Advisors - A Westwood Trust Company, which increased Private Wealth assets under management to 26% of our consolidated assets under management.
|
||||||
|
(1)
|
Pursuant to the terms of Ms. Kice's Offer Letter, she was entitled to a minimum cash bonus target of $225,000 in February 2016, subject to Compensation Committee approval.
|
|
Name
|
|
Number of Restricted Shares Granted (#)
|
|
Grant Date Fair Value of Shares ($) (1) (j)
|
||
|
Tiffany B. Kice
|
|
3,640
|
|
|
224,588
|
|
|
Julie K. Gerron
|
|
4,044
|
|
|
249,515
|
|
|
Randall L. Root
|
|
4,044
|
|
|
249,515
|
|
|
(1)
|
The amounts in column (j) reflect the grant date fair value of time-vested restricted stock award granted to Mses. Kice and Gerron and Mr. Root in 2015, computed in accordance with ASC 718 (except that no assumptions for forfeitures were included). The assumptions used in the valuation of the restricted stock awards are discussed in Note 9 “Employee Benefits” of our audited financial statements, included in our 2015 Form 10-K. The grant date fair value for time-vested awards for Mses. Kice and Gerron and Mr. Root was based on $61.70 per share, which was the closing price of our common stock on the grant date of February 23, 2015, adjusted for the accrual of dividends on unvested shares.
|
|
•
|
50% in performance shares that are earned based upon an adjusted pre-tax income goal for 2016, which vest ratably over a three-year period, and
|
|
•
|
50% in performance shares that are earned based upon a distinct adjusted pre-tax income target for 2016 ("Target Performance shares").
|
|
|
|
COMPENSATION COMMITTEE
|
|
|
|
Richard M. Frank, Chairman
Martin J. Weiland
Raymond E. Wooldridge
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Name and
Principal
Position
(a)
|
|
Year
(b) |
|
Salary
($) (c) (1) |
|
Bonus
($) (d) (2) |
|
Stock
Awards ($) (e) (3) |
|
Non-Equity
Incentive Plan Compensation ($) (f) (4) |
|
All
Other Compensation ($) (g) (5) |
|
Total
($) (h) |
||||||
|
Brian O. Casey,
President and Chief Executive Officer
|
|
2015
|
|
600,000
|
|
|
—
|
|
|
2,090,200
|
|
|
2,065,669
|
|
|
29,150
|
|
|
4,785,019
|
|
|
|
2014
|
|
600,000
|
|
|
—
|
|
|
2,057,650
|
|
|
1,994,401
|
|
|
28,600
|
|
|
4,680,651
|
|
|
|
|
2013
|
|
587,500
|
|
|
—
|
|
|
1,532,650
|
|
|
1,503,328
|
|
|
28,050
|
|
|
3,651,528
|
|
|
|
Tiffany B. Kice,
Senior Vice President, Chief Financial Officer & Treasurer
|
|
2015
|
|
225,000
|
|
|
250,000
|
|
|
224,588
|
|
|
—
|
|
|
29,150
|
|
|
728,738
|
|
|
|
2014
|
|
84,375
|
|
|
110,000
|
|
|
74,888
|
|
|
—
|
|
|
64,219
|
|
|
333,482
|
|
|
|
Mark R. Freeman,
Executive Vice President and Chief Investment Officer
|
|
2015
|
|
500,000
|
|
|
—
|
|
|
1,242,400
|
|
|
2,032,835
|
|
|
29,150
|
|
|
3,804,385
|
|
|
|
2014
|
|
500,000
|
|
|
250,000
|
|
|
1,175,800
|
|
|
1,997,201
|
|
|
28,600
|
|
|
3,951,601
|
|
|
|
|
2013
|
|
500,000
|
|
|
250,000
|
|
|
875,800
|
|
|
751,664
|
|
|
28,050
|
|
|
2,405,514
|
|
|
|
Julie K. Gerron,
Senior Vice President, General Counsel and Corporate Secretary
|
|
2015
|
|
208,333
|
|
|
190,000
|
|
|
249,515
|
|
|
—
|
|
|
29,150
|
|
|
676,998
|
|
|
|
2014
|
|
196,667
|
|
|
190,000
|
|
|
251,621
|
|
|
—
|
|
|
28,600
|
|
|
666,888
|
|
|
|
|
2013
|
|
178,333
|
|
|
160,000
|
|
|
227,708
|
|
|
—
|
|
|
28,050
|
|
|
594,091
|
|
|
|
Randall L. Root,
President, Westwood Trust Dallas |
|
2015
|
|
250,000
|
|
|
250,000
|
|
|
249,515
|
|
|
—
|
|
|
29,150
|
|
|
778,665
|
|
|
|
2014
|
|
247,917
|
|
|
200,000
|
|
|
269,729
|
|
|
—
|
|
|
28,600
|
|
|
746,246
|
|
|
|
|
2013
|
|
235,417
|
|
|
225,000
|
|
|
249,603
|
|
|
—
|
|
|
28,050
|
|
|
738,070
|
|
|
|
(1)
|
This column represents base compensation earned during each of the fiscal years presented.
|
|
(2)
|
Messrs. Freeman and Root and Mses. Kice and Gerron were granted non-plan cash incentive awards from a Company bonus pool, which was not based upon any pre-established performance goals. Pursuant to the terms of Ms. Kice’s Offer Letter, she was entitled to a minimum cash bonus target of $225,000 for 2015 and $225,000 for 2014, prorated for her partial service in the 2014 performance year as determined by her start date.
|
|
(3)
|
For 2015, the amounts contained in column (e) reflect (i) for Mr. Casey, the grant date fair value of his 2015 performance-based restricted stock award that was subject to vesting in 2015 (35,000 shares), (ii) for Ms. Kice, the grant date fair value of her time-vested restricted stock award granted in 2015 (3,640 shares), (iii) for Mr. Freeman, the grant date fair value of the tranche of his 2012 performance-based restricted stock award that was subject to vesting in 2015 (20,000 shares), (iv) for Ms. Gerron, the grant date fair value of her time-vested restricted stock award granted in 2015 (4,044 shares), and (v) for Mr. Root, the grant date fair value of his time-vested restricted stock award granted in 2015 (4,044 shares).
|
|
(4)
|
The amounts in column (f) reflect the cash payment of 3% of our adjusted pre-tax income, as defined, for the respective year to Mr. Casey, in accordance with his annual cash incentive award. The amount for Mr. Freeman includes: cash payment of 1.5% of our adjusted pre-tax income, as defined, for the respective year; and for 2015 $1.0 million in mutual fund shares earned under the terms of the Mutual Fund Share Incentive Agreement dated March 4, 2015
|
|
(5)
|
The amounts in column (g) reflect each named executive officer’s 401(k) Company matching contribution and Company profit sharing contribution under the Savings Plan. See the “Compensation Discussion and Analysis” section above for a further description of the plan contributions in 2015. For Ms. Kice, the amount in 2014 includes a $50,000 cash signing bonus pursuant to the terms of her Offer Letter.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
Estimated Future Payouts Under Non-Equity Incentive Plan Awards
|
|
Estimated Future Payouts Under Equity Incentive Plan Awards
|
|
All
Other Stock Awards: Number of Shares of Stock (#) (i) (3) |
|
Grant Date
Fair Value of Stock ($) (j) (4) |
||||||||||||||||
|
Name
(a)
|
|
Grant
Date (b) |
|
Threshold
($) (c) |
|
Target
($) (d) (1) |
|
Maximum
($) (e) |
|
Threshold
(#) (f) |
|
Target
(#) (g) (2) |
|
Maximum
($) (e) |
|
|||||||||||
|
Brian O. Casey
|
|
3/4/15
|
|
N/A
|
|
|
2,065,669
|
|
|
N/A
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
3/28/15
|
|
—
|
|
|
—
|
|
|
—
|
|
|
N/A
|
|
|
35,000
|
|
|
N/A
|
|
|
—
|
|
|
2,090,200
|
|
|
|
Tiffany B. Kice
|
|
02/24/15
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,640
|
|
|
224,588
|
|
|
Mark R. Freeman
|
|
3/4/15
|
|
—
|
|
|
—
|
|
|
—
|
|
|
N/A
|
|
|
20,000
|
|
|
N/A
|
|
|
—
|
|
|
1,242,400
|
|
|
|
3/4/15
|
|
N/A
|
|
|
1,032,835
|
|
|
N/A
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
3/4/15
|
|
—
|
|
|
500,000
|
|
|
1,000,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Julie K. Gerron
|
|
2/24/15
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,044
|
|
|
249,515
|
|
|
Randall L. Root
|
|
2/24/15
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,044
|
|
|
249,515
|
|
|
(1)
|
The amounts in column (d) reflect the payment of 3% and 1.5% of our 2015 adjusted pre-tax income to Mr. Casey and Mr. Freeman, respectively, in accordance with their annual cash incentive awards.
|
|
(2)
|
The amounts in column (g) reflect the tranche of Mr. Casey’s and Mr. Freeman’s performance-based restricted stock awards subject to vesting in 2015 upon our adjusted pre-tax income for 2015 being at least $46 million. There were no threshold or maximum award levels (or equivalent items) for these performance-based annual restricted stock awards. See the “Compensation Discussion and Analysis” section above for a further description of performance-based restricted stock incentive awards.
|
|
(3)
|
The amount in column (i) reflects time-vested restricted stock award granted to Mses. Kice and Gerron and Mr. Root in 2015. The shares vest as follows: 50% after two years; 75% after three years; and 100% after four years.
|
|
(4)
|
The amounts in column (j) reflect the grant date fair value of (i) the tranche of Mr. Casey’s and Mr. Freeman’s performance-based restricted stock award subject to vesting in 2015, and (ii) Mses. Kice’s and Gerron’s and Mr. Root’s time-vested restricted stock awards granted in 2015, computed in accordance with ASC 718 (except that no assumptions for forfeitures were included). The assumptions used in the valuation of the restricted stock awards are discussed in Note 9 “Employee Benefits” of our audited financial statements, included in our 2015 Form 10-K. The grant date fair value for Ms. Kice's and Gerron’s and Mr. Root’s time –vested awards was based on $61.70 per share, which was the closing price of our common stock on the grant date of February 23, 2015, adjusted for the accrual of dividends on unvested shares. The grant date fair value for Mr. Casey's award was $59.72, which was based on the closing price of our common stock on the grant date of March 28, 2015, adjusted for the accrual of dividends. The grant date fair value for Mr. Freeman’s awards was $62.12, which was based on the closing price of our common stock on the grant date of March 4, 2015, adjusted for the accrual of dividends.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
Option Awards
|
|
Stock Awards
|
|||||||||||||||||
|
Name
(a)
|
|
Number of
Securities Underlying Unexercised Options (#) Exercisable (b) |
|
Option
Exercise
Price
($)
(e)
|
|
Option
Expiration Date (f) |
|
Number
of
Shares
of Stock
That
Have
Not
Vested
(#)
(g)
(1)
|
|
Market
Value
of
Shares
of Stock
That
Have
Not Vested
($)
(h)
(3)
|
|
Equity
Incentive
Plan
Awards:
Number
of
Unearned
Shares
That
Have
Not
Vested
(#)
(i)
(2)
|
|
Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares
That Have
Not Vested
($)
(j)
(3)
|
|||||||
|
Brian O. Casey
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
35,000
|
|
|
1,823,150
|
|
|
Tiffany B. Kice
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,916
|
|
|
256,074
|
|
|
—
|
|
|
—
|
|
|
Mark R. Freeman
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,387
|
|
|
124,339
|
|
|
40,000
|
|
|
2,083,600
|
|
|
Julie K. Gerron
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,224
|
|
|
636,748
|
|
|
—
|
|
|
—
|
|
|
Randall L. Root
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,907
|
|
|
672,326
|
|
|
—
|
|
|
—
|
|
|
(1)
|
The shares in column (g) will vest in late February of each year, with the exception of Ms. Kice's October 2014 grant, which will vest in October of each year, according to the following schedule provided that the individual is, in most cases, still employed by us on the vesting date.
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
Shares scheduled to vest
|
||||||||||
|
Name
|
|
2016
|
|
2017
|
|
2018
|
|
2019
|
||||
|
Tiffany B. Kice
|
|
638
|
|
|
2,139
|
|
|
1,229
|
|
|
910
|
|
|
Mark R. Freeman
|
|
2,387
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Julie K. Gerron
|
|
4,740
|
|
|
4,392
|
|
|
2,081
|
|
|
1,011
|
|
|
Randall L. Root
|
|
5,144
|
|
|
4,594
|
|
|
2,158
|
|
|
1,011
|
|
|
(2)
|
The shares in column (i) represent an unearned, performance-based restricted stock incentive award granted to Mr. Casey in 2015 and Mr. Freeman in 2012 under the Stock Incentive Plan, which will vest according to the following schedule, provided that Mr. Casey and Mr. Freeman are, in most cases, still employed by us on the vesting date and the applicable performance goal is achieved for the respective year. Each year during the applicable vesting period, the Compensation Committee will establish a specific goal for that year’s vesting of the restricted shares. The performance goal will be based upon criteria set forth in the Stock Incentive Plan. The specific performance goal for each year will be established no later than March 31 of the vesting year. If in any year during the vesting period the performance goal is not met, the Compensation Committee may establish a goal for a subsequent vesting period, which if achieved or exceeded may result in full or partial vesting of the shares that did not otherwise become vested in a prior year. See the “Compensation Discussion and Analysis” section above for a further description of this performance-based restricted stock incentive award.
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
Shares scheduled to vest
|
|||||||||
|
Name
|
|
2016
|
|
2017
|
|
2018
|
|
2019
|
|||
|
Brian O. Casey
|
|
35,000
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Mark Freeman
|
|
20,000
|
|
20,000
|
|
|
—
|
|
|
—
|
|
|
(3)
|
The amounts in columns (h) and (j) reflect the value of the shares shown in columns (g) and (i), respectively, multiplied by $52.09, the closing market price of our common stock as of December 31, 2015, the last business day in 2015.
|
|
|
|
|
|
|
||
|
|
|
Stock Awards
|
||||
|
Name
(a)
|
|
Number of Shares
Acquired on
Vesting (#)
(a)
|
|
Value Realized
on
Vesting ($)
(b)
(1)
|
||
|
Brian O. Casey
|
|
35,000
|
|
|
2,163,700
|
|
|
Mark R. Freeman
|
|
24,762
|
|
|
1,530,787
|
|
|
Julie K. Gerron
|
|
5,150
|
|
|
318,373
|
|
|
Randall L. Root
|
|
5,650
|
|
|
349,283
|
|
|
(1)
|
Values in column (b) reflect shares that vested as of February 23, 2015 at a market value of $61.82 per share, including 35,000 shares of performance-based restricted stock for Mr. Casey; 4,762 shares of time-vested restricted stock and 20,000 shares of performance-based restricted stock for Mr. Freeman; 5,150 shares of time-vested restricted stock for Ms. Gerron; and 5,650 shares of time-vested restricted stock for Mr. Root.
|
|
•
|
an amount equal to 1.5 times the sum of one year's worth of salary and the annual bonus paid to Mr. Casey for the most recently completed year, to be paid in monthly installments over eighteen months;
|
|
•
|
all unvested stock options and unvested restricted shares shall be fully vested; provided, however, that to the extent that any such awards are subject to performance-based vesting conditions that are intended to qualify for the performance-based compensation exemption under Section 162(m) of the Internal Revenue Code, then those awards will only become vested if and to the extent that such awards would have become vested in accordance with their terms if Mr. Casey's employment had continued; and provided further that, if such award is subject to periodic vesting based upon performance conditions established for each vesting period, then the annual performance conditions applicable to any such award following the termination of Mr. Casey's employment shall be the same as the last periodic performance goal established with respect to such award prior to the termination of Mr. Casey's employment or, if more favorable to Mr. Casey, the periodic performance conditions established for performance-based vesting of equity or equity-based awards granted to other senior executives who are then still employed by the Company.
|
|
•
|
amounts earned by the executive during his employment;
|
|
•
|
one year's worth of salary paid in monthly installments, less the amount of medical insurance premiums the executive would have paid had he remained employed;
|
|
•
|
bonus and incentive compensation earned by the executive as of the termination date;
|
|
•
|
vacation time that was earned and unused by the executive; and
|
|
•
|
medical benefits for the executive and his eligible dependents for twelve months following termination.
|
|
•
|
amounts earned by the executive during his employment;
|
|
•
|
bonus and incentive compensation earned by the executive as of the termination date;
|
|
•
|
vacation time that was earned and unused by the executive; and
|
|
•
|
medical benefits for the executive and his eligible dependents for twelve months following termination.
|
|
•
|
an amount equal to two times the sum of one year's worth of salary and the annual bonus paid to Mr. Casey for the most recently completed year, to be paid in monthly installments over twenty-four months;
|
|
•
|
bonus and incentive compensation earned by the executive as of the termination date;
|
|
•
|
vacation time that was earned and unused by the executive;
|
|
•
|
medical benefits for the executive's eligible dependents for eighteen months following termination; and
|
|
•
|
all unvested stock options and all unvested restricted shares shall be fully vested; provided, however, that to the extent that any such awards are subject to performance-based vesting conditions, the performance goals were achieved at 100% of the target performance. In March 2016, we entered into a Performance Share Agreement with Mr. Casey that provides the unvested restricted shares subject to the award will vest upon a change in control as follows: (a) if the change in control occurs before the last day of the one-year performance cycle, 50% of the shares covered by the award (the "Category 1 Shares") will vest and the remaining 50% (the "Category 2 Shares") will vest assuming target level performance or (b) if the change in control occurs after the end of the performance cycle, all Category 1 Shares and Category 2 Shares will fully vest to the extent then-earned based on the Company's actual performance for the performance cycle.
|
|
•
|
amounts earned by the executive during his employment;
|
|
•
|
bonus and incentive compensation earned by the executive as of the termination date;
|
|
•
|
vacation time that was earned and unused by the executive;
|
|
•
|
medical benefits for the executive's eligible dependents for eighteen months following termination; and
|
|
•
|
all unvested stock options and all unvested restricted shares shall be fully vested.
|
|
•
|
vacation time that was earned and unused by the executive;
|
|
•
|
disability benefits, if any, at least equal to those then provided by the Company to disabled executives and their families;
|
|
•
|
medical benefits for the executive's eligible dependents for twelve months following termination; and
|
|
•
|
all unvested stock options and all unvested restricted shares shall be fully vested.
|
|
•
|
amounts earned by the executive during his employment;
|
|
•
|
three months’ worth of salary paid in monthly installments, less the amount of medical insurance premiums the executive would have paid had he remained employed;
|
|
•
|
bonus and incentive compensation earned by the executive as of the termination date;
|
|
•
|
not less than four weeks of vacation time that was earned and unused by the executive;
|
|
•
|
medical benefits for the executive and his eligible dependents for three months following termination; and
|
|
•
|
all unvested stock options, all unvested restricted shares and all unvested mutual fund share bonus awards shall become vested and exercisable; provided however, that if any such unvested equity or equity-based award is subject to performance-based vesting conditions that are intended to qualify for the performance-based compensation exemption under Section 162(m) of the Code, then such award will become vested only if, when and to the extent such award would have become vested in accordance with its terms if Mr. Freeman’s employment had continued; and provided further that, if such award is subject to periodic vesting based upon performance conditions established for each vesting period, then the annual performance conditions applicable to any such award following the termination of Mr. Freeman’s employment shall be the same as the last periodic performance goal established with respect to such award prior to the termination of Mr. Freeman’s employment or, if more favorable to Mr. Freeman, the periodic performance conditions established for performance-based vesting of equity or equity-based awards granted to other senior executives who are then still employed by the Company.
|
|
•
|
all unvested stock options, all unvested restricted shares and all unvested mutual fund share bonus awards shall become vested and exercisable; provided however, that if any such unvested equity or equity-based award is subject to performance-based vesting conditions that are intended to qualify for the performance-based compensation exemption under Section 162(m) of the Code, then such award will become vested only if, when and to the extent such award would have become vested in accordance with its terms if Mr. Freeman’s employment had continued; and provided further that, if such award is subject to periodic vesting based upon performance conditions established for each vesting period, then the annual performance conditions applicable to any such award following the termination of Mr. Freeman’s employment shall be the same as the last periodic performance goal established with respect to such award prior to the termination of Mr. Freeman’s employment or, if more favorable to Mr. Freeman, the periodic performance conditions established for performance-based vesting of equity or equity-based awards granted to other senior executives who are then still employed by the Company.
|
|
•
|
three months’ worth of salary paid in monthly installments, less the amount of medical insurance premiums the executive would have paid had he remained employed;
|
|
•
|
three months’ worth of salary paid in monthly installments, less the amount of medical insurance premiums the executive would have paid had he remained employed;
|
|
•
|
three months’ worth of salary paid in monthly installments, less the amount of medical insurance premiums the executive would have paid had he remained employed;
|
|
•
|
all unexercised stock options, all unvested restricted shares, all unvested mutual fund share bonus awards and all other unvested equity-incentive compensation awards shall become vested and exercisable.
|
|
•
|
all unexercised stock options, all unvested restricted shares, all unvested mutual fund share bonus awards and all other equity-incentive compensation awards theretofore granted shall become vested and exercisable.
|
|
•
|
disability benefits, if any, at least equal to those then provided by the Company to disabled executives and their families;
|
|
•
|
all unexercised stock options, all unvested restricted shares, all unvested mutual fund share bonus awards and all other equity-incentive compensation awards shall become vested and exercisable.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Benefits/payments upon termination
|
|
For cause, voluntary
termination without good reason or non-renewal by the executive |
|
Without cause, for good reason or non-renewal by the Company
|
|
Resign with
good reason or terminated due to
change
in control |
|
Death
|
|
Disability
|
||||||||||||||
|
Non-compete enforced?
|
|
Y
|
|
N
|
|
Y
|
|
Y
|
|
N/A
|
|
N/A
|
||||||||||||
|
Base salary for an additional period
(1)
|
|
$
|
646,316
|
|
|
$
|
—
|
|
|
$
|
975,000
|
|
|
$
|
1,300,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Annual bonus for an additional period
(2)
|
|
—
|
|
|
—
|
|
|
3,098,504
|
|
|
4,131,338
|
|
|
—
|
|
|
—
|
|
||||||
|
Performance shares
(3)
|
|
—
|
|
|
—
|
|
|
1,823,150
|
|
|
1,823,150
|
|
|
1,823,150
|
|
|
1,823,150
|
|
||||||
|
Medical benefits
(4)
|
|
12,782
|
|
|
12,782
|
|
|
19,173
|
|
|
19,173
|
|
|
19,173
|
|
|
12,782
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Total
|
|
$
|
659,098
|
|
|
$
|
12,782
|
|
|
$
|
5,915,827
|
|
|
$
|
7,273,661
|
|
|
$
|
1,842,323
|
|
|
$
|
1,835,932
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
(1)
|
Amounts reflect one year’s base salary, less the amount of medical insurance premiums the executive would have paid had he remained employed with the Company, for termination for cause, voluntary termination without good reason or non-renewal by the executive. Amounts reflect 1.5 times Mr. Casey's annual base salary, less the amount of medical insurance premiums the executive would have paid had he remained employed with the Company, for termination without cause, for good reason or non-renewal by the Company. Amounts reflect 2 times Mr. Casey's annual base salary, less the amount of medical insurance premiums the executive would have paid had he remained employed with the Company, for termination due to change in control.
|
|
(2)
|
Amounts reflect 1.5 times Mr. Casey's annual bonus paid for the most recently completed year for termination without cause, for good reason or non-renewal by the Company. Amounts reflect two times Mr. Casey's annual bonus paid for the most recently completed year for termination due to change in control.
|
|
(3)
|
Amounts reflect the estimated value of the acceleration of the executive’s outstanding performance-based restricted stock awards (35,000 shares, which are equal to the number of outstanding performance-based restricted stock shares that are reported in the “Outstanding Equity Awards at December 31, 2015” table), using our closing stock price of $52.09 per share as of the last day of business in 2015.
|
|
(4)
|
The amount reflects the Company’s estimated premiums to continue medical benefits for the executive and his dependents, as applicable, for twelve months after termination for cause, voluntary termination without good reason, non-renewal by the executive or disability, or for eighteen months after termination without cause, for good reason, non-renewal by the Company, change in control or death.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Benefits/payments upon termination
|
|
For cause or voluntary
termination without
good reason
|
|
Without cause/resign with
good reason
|
|
Resign with
good reason
or terminated
due to
change
in control
|
|
Death
|
|
Disability
|
||||||||||||||||||
|
Mandatory inactivity period enforced?
|
|
Y
|
|
N
|
|
Y
|
|
N
|
|
Y
|
|
N/A
|
|
N/A
|
||||||||||||||
|
Base salary for an additional three months (1)
|
|
$
|
123,764
|
|
|
$
|
—
|
|
|
$
|
123,764
|
|
|
$
|
—
|
|
|
$
|
123,764
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Restricted shares (2)
|
|
—
|
|
|
—
|
|
|
2,207,939
|
|
|
2,207,939
|
|
|
2,207,939
|
|
|
2,207,939
|
|
|
2,207,939
|
|
|||||||
|
Medical benefits (3)
|
|
3,981
|
|
|
—
|
|
|
3,981
|
|
|
—
|
|
|
3,981
|
|
|
15,925
|
|
|
15,925
|
|
|||||||
|
Acceleration of Payment of Mutual Fund Bonus Award (4)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,000,000
|
|
|
1,000,000
|
|
|
1,000,000
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Total
|
|
$
|
127,745
|
|
|
$
|
—
|
|
|
$
|
2,335,684
|
|
|
$
|
2,207,939
|
|
|
$
|
3,335,684
|
|
|
$
|
3,223,864
|
|
|
$
|
3,223,864
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
(1)
|
Amounts reflect three months’ base salary, less the amount of medical insurance premiums Mr. Freeman would have paid had he remained employed with the Company.
|
|
(2)
|
Amounts reflect the estimated value of acceleration of Mr. Freeman’s outstanding time-vested and performance-based restricted stock awards (2,387 shares, which is equal to the number of outstanding time-vested restricted stock shares that are reported in the “Outstanding Equity Awards at December 31, 2015” table, and 40,000 shares, which is equal to the number of outstanding performance-based restricted stock shares that are reported in the “Outstanding Equity Awards at December 31, 2015” table), using our closing stock price of $52.09 per share as of the last day of business in 2015.
|
|
(3)
|
The amount reflects the Company’s estimated premiums to continue medical benefits for Mr. Freeman and his dependents, as applicable, for three months after termination, except in the case of termination due to Mr. Freeman’s death or disability, in which case medical benefits for Mr. Freeman and his dependents, as applicable, continue for twelve months after termination.
|
|
(4)
|
In the event of Mr. Freeman’s termination due to death or disability, or his involuntary termination without cause or voluntary termination for good reason following a change in control, he would vest immediately in his outstanding unvested mutual fund awards. As of December 31, 2015, Mr. Freeman had $1 million unvested mutual fund awards.
|
|
•
|
amounts paid under other benefit plans, including our family and medical leave of absence and long-term disability programs.
|
|
•
|
a merger or consolidation of the Company with or into another corporation in which the Company shall not be the surviving corporation (other than a merger undertaken solely in order to reincorporate in another state) (for purposes hereof, the Company shall not be deemed the surviving corporation in any such transaction if, as the result thereof, it becomes a wholly-owned subsidiary of another corporation);
|
|
•
|
a dissolution of the Company;
|
|
•
|
a transfer of all or substantially all of the assets of the Company in one transaction or a series of related transactions to one or more other persons or entities; or
|
|
•
|
a transaction or series of transactions that results in any entity, person, or group, becoming the beneficial owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company’s then outstanding securities; or during any period of two consecutive years commencing on or after January 1, 2005, individuals who at the beginning of the period constituted the Company’s Board of Directors cease for any reason to constitute at least a majority, unless the election of each director who was not a director at the beginning of the period has been approved in advance by directors representing at least two-thirds of the directors then in office who were directors at the beginning of the period; provided, however, that a “Change in Control” shall not be deemed to have occurred if the ownership of 50% or more of the combined voting power of the surviving corporation, asset transferee or Company (as the case may be), after giving effect to the transaction or series of transactions, is directly or indirectly held by (A) a trustee or other fiduciary under an employee benefit plan maintained by the Company, or (B) one or more of the “executive officers” of the Company that held such positions prior to the transaction or series of transactions, or any entity, person or group under their control.
|
|
•
|
executive’s conviction of any felony or other serious crimes;
|
|
•
|
executive’s material breach of any of the terms of the employment agreement or any other written agreement or material company policy to which the executive and the Company are parties or are bound (or, in the case of Mr. Freeman, personal misconduct that is materially detrimental to the best interests of the Company), if such breach (or, in the case of Mr. Freeman, personal misconduct) shall be willful and shall continue beyond a period of 30 days (in the case of Mr. Casey) or 20 days (in the case of Mr. Freeman) immediately after written notice thereof by the Company to the executive;
|
|
•
|
wrongful misappropriation by the executive of any money, assets, or other property of the Company or a client of the Company;
|
|
•
|
willful actions or failures to act by the executive which subject the executive or the Company to censure by the Securities and Exchange Commission as described in and pursuant to Section 203(e) or 203(f) of the Investment Advisers Act of 1940 or Section 9(b) of the Investment Company Act of 1940 or to censure by a state securities administrator pursuant to applicable state securities laws or regulations;
|
|
•
|
executive’s commission of fraud or gross moral turpitude; or
|
|
•
|
executive’s continued willful failure to substantially perform executive’s duties under the applicable agreement after receipt of written notice thereof and an opportunity to so perform.
|
|
•
|
any material breach by the Company of the employment agreement (including any reduction in the executive’s base salary);
|
|
•
|
any material adverse change in the status, position or responsibilities of the executive, including in the case of Mr. Casey a change in the executive’s reporting relationship so that he no longer reports to the Board of Directors, the removal from or failure to re-elect the executive as a member of the Board or if the Company becomes a wholly-owned subsidiary of another company, and the executive serves only as an officer of the subsidiary company;
|
|
•
|
assignment of duties to the executive that are materially inconsistent with the executive’s position and responsibilities described in his employment agreement;
|
|
•
|
the failure of the Company to assign the employment agreement to a successor to the Company or failure of a successor to the Company to explicitly assume and agree to be bound by the employment agreement; or
|
|
•
|
requiring the executive to be principally based at any office or location more than 40 miles (in the case of Mr. Casey) or 25 miles (in the case of Mr. Freeman) from the current offices of the Company in Dallas, Texas.
|
|
•
|
a merger or consolidation of the Company with or into another corporation (other than a merger undertaken solely in order to reincorporate in another state) immediately following which the beneficial holders of the voting stock of the Company immediately prior to such transaction or series of transactions do not continue to hold 50% or more of the voting stock (based upon voting power) of the Company or (A) any entity that owns, directly or indirectly, the stock of the Company, (B) any entity with which the Company has merged, or (C) any entity that owns an entity with which the Company has merged;
|
|
•
|
a dissolution of the Company;
|
|
•
|
a transfer of all or substantially all of the assets of the Company in one or more related transactions to one or more other persons or entities;
|
|
•
|
a transaction or series of transactions that results in any entity, “Person” or “Group”, becoming the beneficial owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company’s then outstanding securities; or
|
|
•
|
during any period of two consecutive years commencing on or after January 1, 2016 (in the case of Mr. Casey) or January 1, 2012 (in the case of Mr. Freeman), individuals who at the beginning of the period constituted the Company’s Board of Directors cease for any reason to constitute at least a majority, unless the election of each director who was not a director at the beginning of the period has been approved in advance by directors representing at least two-thirds (2/3) of the directors then in office who were directors at the beginning of the period; provided, however, that a “Change in Control” shall not be deemed to have occurred if the ownership of 50% or more of the combined voting power of the surviving corporation, asset transferee or Company (as the case may be), after giving effect to the transaction or series of transactions, is directly or indirectly held by (A) a trustee or other fiduciary under an employee benefit plan maintained by the Company, or (B) one or more of the “executive officers” of the Company that held such positions prior to the transaction or series of transactions, or any entity, Person or Group under their control.
|
|
|
|
|
|
|
|
|
|||
|
Plan Category
|
|
Number of
securities to be issued upon exercise of outstanding options (a) |
|
Weighted-
average exercise price of outstanding options (b) |
|
Number of
securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c) |
|||
|
Equity compensation plans approved by security holders
|
|
—
|
|
|
—
|
|
|
679,000
|
|
|
Equity compensation plans not approved by security holders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|||
|
Total
|
|
—
|
|
|
—
|
|
|
679,000
|
|
|
|
|
|
|
|
|
|
|||
|
•
|
each stockholder known by us to own more than five percent (5%) of outstanding common stock;
|
|
•
|
each director and director nominee;
|
|
•
|
each named executive officer; and
|
|
•
|
all directors and executive officers as a group.
|
|
|
|
|
|
|
|
|
Beneficial Owners
|
|
Number of Shares
Beneficially Owned |
|
Percent of
Class |
|
|
5% Beneficial Owners
|
|
|
|
|
|
|
Royce & Associates, LLC
(2)(3)
|
|
716,275
|
|
8.2
|
%
|
|
GAMCO Investors, Inc.
(2)(4)
|
|
631,018
|
|
7.2
|
%
|
|
BlackRock Inc.
(2)(5)
|
|
540,917
|
|
6.2
|
%
|
|
Conestoga Capital Advisors, LLC
(2)(6)
|
|
454,085
|
|
5.2
|
%
|
|
Directors and Named Executive Officers
(1)
|
|
|
|
|
|
|
Brian O. Casey
|
|
254,509
|
|
2.9
|
%
|
|
Mark R. Freeman
|
|
91,025
|
|
1.0
|
%
|
|
Tiffany B. Kice
|
|
10,180
|
|
*
|
|
|
Julie K. Gerron
|
|
30,641
|
|
*
|
|
|
Randall L. Root
|
|
37,317
|
|
*
|
|
|
Richard M. Frank
|
|
26,035
|
|
*
|
|
|
Susan M. Byrne
|
|
333,739
|
|
3.8
|
%
|
|
Ellen H. Masterson
|
|
3,015
|
|
*
|
|
|
Robert D. McTeer
|
|
14,515
|
|
*
|
|
|
Geoffrey R. Norman
|
|
6,265
|
|
*
|
|
|
Martin J. Weiland
|
|
7,515
|
|
*
|
|
|
Raymond E. Wooldridge
|
|
54,430
|
|
*
|
|
|
All directors and named executive officers as a group (12 Persons)
|
|
869,186
|
|
10.1
|
%
|
|
*
|
Less than 1%
|
|
(1)
|
The address of each director and named executive officer is 200 Crescent Court, Suite 1200, Dallas, Texas, 75201.
|
|
(2)
|
The beneficial ownership information reported for this stockholder is based upon the most recent Form 13F, Schedule 13G or Schedule 13D filed with the SEC by such stockholder.
|
|
(3)
|
The address of Royce & Associates, LLC is 745 Fifth Avenue, New York, NY 10151. On January 28, 2016, Royce & Associates reported its beneficial ownership, indicating that it held sole dispositive power and sole voting power over 716,275 shares.
|
|
(4)
|
The address of GAMCO Investors, Inc., or GAMCO is One Corporate Center, Rye, NY 10580. On February 5, 2016, GAMCO reported its beneficial ownership, indicating that it held sole voting power over 631,018 shares.
|
|
(5)
|
The address of BlackRock, Inc. is 55 East 52
nd
Street, New York, New York 10055. On January 27, 2016, BlackRock, Inc. reported its beneficial ownership, indicating that it held sole dispositive power over 558,033 shares and sole voting power over 540,917 shares.
|
|
(6)
|
The address of Conestoga Capital Advisors, LLC is 550 E. Swedesford Road, Suite 120, Wayne, PA 19087. On January 8, 2016, Conestoga Capital Advisors, LLC reported its beneficial ownership, indicating that it held sole dispositive power over 579,785 shares and sole voting power over 454,085 shares.
|
|
|
|
AUDIT COMMITTEE
|
|
|
|
Raymond E. Wooldridge, Chairman
Richard M. Frank
Geoffrey R. Norman
Ellen H. Masterson
|
|
•
|
If the shares are registered in the name of the stockholder, stockholders should contact us at our offices at 200 Crescent Court, Suite 1200, Dallas Texas 75201, Attention: Corporate Secretary, or by telephone at 214-756-6900, to inform Westwood of their request.
|
|
•
|
If a bank, broker or other nominee holds the shares, stockholders should contact the bank, broker or other nominee directly.
|
|
|
|
By Order of the Board of Directors,
|
|
|
|
|
Brian O. Casey
|
|
President and Chief Executive Officer
|
|
|
|
|
|
|
|
n
|
|
|
|
|
|
n
1.1
|
|
14475
n
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommends a vote “FOR” all director nominees in Proposal 1 and “FOR” Proposals 2 and 3.
|
|
|||||||||||||||
|
|
|
PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE
x
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
|
|
1. Election of eight directors to hold office until the next annual meeting of Westwood’s stockholders and until their respective successors shall have been duly elected and qualified.
|
|
|
|
2. Ratification of the appointment of Deloitte & Touche LLP as Westwood’s independent auditors for the year ending December 31, 2016.
|
|
o
|
|
o
|
|
o
|
|
|
||||||
|
|
|
|
|
NOMINEES:
|
|
|
|
|
|
|
|
|
|
|
||||
|
o
|
|
FOR ALL NOMINEES
|
|
O Brian O. Casey
O Richard M. Frank
O Susan M. Byrne
O Ellen H. Masterson
O Robert D. McTeer
O Geoffrey R. Norman
O Martin J. Weiland
O Raymond E. Wooldridge
|
|
|
|
3. Approval of the Third Amendment to the Third Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan.
|
|
o
|
|
o
|
|
o
|
|
|
||
|
o
|
|
WITHHOLD AUTHORITY
FOR ALL NOMINEES
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
o
|
|
FOR ALL EXCEPT
(See instructions below)
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
4. IN THEIR DISCRETION, THE PROXIES ARE AUTHORIZED TO VOTE UPON SUCH OTHER MATTERS AS MAY PROPERLY COME BEFORE THE ANNUAL MEETING OR ANY POSTPONEMENTS OR ADJOURNMENTS THEREOF.
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
INSTRUCTIONS:
To withhold authority to vote for any individual nominee(s), mark “
FOR ALL EXCEPT
” and fill in the circle next to each nominee you wish to withhold, as shown here:
l
|
|
|
|
THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN ACCORDANCE WITH THE SPECIFICATIONS MADE BELOW, BUT IF NO CHOICE IS INDICATED, THIS PROXY WILL BE VOTED “FOR” ALL DIRECTOR NOMINEES IN PROPOSAL 1 AND “FOR” PROPOSALS 2 AND 3, AND IN THE DISCRETION OF THE PROXIES WITH RESPECT TO ANY OTHER MATTER AS MAY PROPERLY COME BEFORE THE MEETING OR ANY POSTPONEMENTS OR ADJOURNMENTS THEREOF.
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.
|
|
o
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature of Stockholder
|
|
|
Date:
|
|
|
Signature of Stockholder
|
|
Date:
|
|
|||||||
|
|
|
n
|
|
Note:
|
|
Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|
|
n
|
||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|